Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 73124 CHICAGO, IL
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,589
-$22,824 QoQ
Shares Held
80,823
+11.2% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 48 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. VTGN ranks #409 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in VTGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,589 80,823
2026-03-31 $41,413 72,655
2025-12-31 $47,952 72,655
2025-09-30 $170,730 48,093
2025-06-30 $96,186 48,093
2025-03-31 $120,232 48,093
2024-12-31 $133,372 45,211
2024-09-30 $148,787 49,431
2024-06-30 $173,867 49,962
2024-03-31 $264,095 50,018
2023-12-31 $251,032 48,839
2023-09-30 $76,105 14,524
2023-06-30 $19,360 10,353
2023-03-31 $220,957 1,841,318
2022-12-31 $174,715 1,747,155
2022-09-30 $225,079 1,500,532
2022-06-30 $1,398,361 1,589,048
2022-03-31 $2,027,403 1,635,003
2021-12-31 $3,810,857 1,954,286
2021-09-30 $5,472,963 1,997,432
2021-06-30 $6,549,412 2,079,179
2021-03-31 $560,062 262,940
2020-12-31 $187,151 96,470
2020-09-30 $74,050 105,786
2020-06-30 $42,231 79,682
2020-03-31 $35,060 79,682